Plasma Fractionation Market to grow steadily at ~6.5% CAGR Through The Forecast Period 2019-2023
Market Research Future in the report provides an in-depth analysis of regional data with Growth Potential, Opportunities, Drivers, Industry-Specific Challenges.
Pune, India – July 16, 2019 /MarketersMedia/ —
Rising participation of market players is one of the key factors driving the plasma fractionation market. For instance, in 2018, Grifols acquired 24 plasma donation centers in the United States operated by Biotest Pharmaceuticals Corp. for USD 286 million. With this acquisition, Grifols now owns 249 plasma donation centres to increase its supply of plasma proteins used for therapeutic purposes.
Increasing prevalence of immunodeficiency disorders and rising healthcare expenditure are also boosting the plasma fractionation market in the US region. According to the 2018 study published in the Allergy, Asthma & Clinical Immunology journal, the estimated overall prevalence of immunoglobulin A (IgA) deficiency in the US was approximately 1 in 300 to 1 in 500 persons.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7397
In plasma fractionation process protein products are fractionated from human plasma for the prevention, and treatment of life-threatening conditions such as congenital deficiencies, immunologic disorders, and others.
Global Plasma Fractionation Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 18073 million in 2017 and is projected to grow at a CAGR of 6.5% over the forecast period.
Various other factors such as increasing geriatric population, technological advancements, emerging markets in APAC and RoW, rising plasma collection, and increasing prevalence of respiratory and autoimmune disorders are also expected to propel the growth of the market.
However, the emergence of recombinant alternatives, high cost of advanced products, and unfavourable reimbursement policies can hamper the market growth over the forecast period.
Segmentation
The global plasma fractionation market is segmented based on product, application, end user, and region.
The global market for plasma fractionation, by product is segmented into immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and others. The immunoglobulin segment is further classified as intravenous immunoglobulin (IVIG), subcutaneous immunoglobulin (SCIG), and others. The coagulation factor concentrates segment is further classified as Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, and Factor XIII.
Based on application, the market is segmented into immunology, neurology, hematology, critical care, pulmonology, rheumatology, hemato-oncology, and others.
Based on end user, the market is segmented into hospitals & clinics, clinical research laboratories, academic institutes, and others.
In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.
The plasma fractionation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European plasma fractionation market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The plasma fractionation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The plasma fractionation market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Analysis
The Americas dominated the global market for plasma fractionation owing to the presence of major market players and increasing prevalence of immunodeficiency disorders within the region. According to the 2018 study published in the Allergy, Asthma & Clinical Immunology journal, the estimated overall prevalence of immunoglobulin A (IgA) deficiency in the US was approximately 1 in 300 to 1 in 500 persons.
In 2017, it was estimated that Europe stood second in the global plasma fractionation market. This can be attributed to the increasing technological advancements, and rising R&D investments.
Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the Australian Institute of Health and Welfare, from 2015 to 2016, the total health expenditure was USD 181 billion. Out of this, USD 69 billion was spent on hospitals, which is a real increase of USD 2 billion from the previous year. During the same years, non-government sources spent USD 55.8 billion on health.
On the other hand, the Middle East and Africa held least share in the global plasma fractionation market due to inadequate economic development, especially within the African region.
Browse Premium Research Report Enabled with List of Tables and Figures @ https://www.marketresearchfuture.com/reports/plasma-fractionation-market-7397
LIST OF TABLES
Table 1 Plasma Fractionation Market Synopsis, 2018–2023
Table 2 Plasma Fractionation Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Plasma Fractionation Market, By Region, 2018–2023 (USD Million)
Table 4 Global Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 5 Global Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 6 Global Plasma Fractionation Market, End User, 2018–2023 (USD Million)
Table 7 North America: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 8 North America: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 9 North America: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)
Table 10 US: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
Table 11 US: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 12 US: Plasma Fractionation Market, End User, 2018–2023 (USD Million)
Table 13 Canada:Plasma Fractionation Market,By Product, 2018–2023 (USD Million)
Table 14 Canada: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)
Table 15 Canada: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)
Table 16 South America: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Plasma Fractionation Market
Figure 3 Market Dynamics For Global Plasma Fractionation Market
Figure 4 Plasma Fractionation Market Share, By Product, 2017
Figure 5 Plasma Fractionation Market Share, By Application, 2017
Figure 6 Plasma Fractionation Market Share, End User, 2017
Figure 7 Plasma Fractionation Market Share, By Region, 2017
Figure 8 North America: Plasma Fractionation Market Share, By Country, 2017
Figure 9 Europe: Plasma Fractionation Market Share, By Country, 2017
Figure 10 Asia-Pacific: Plasma Fractionation Market Share, By Country, 2017
Figure 11 Middle East & Africa: Plasma Fractionation Market Share, By Region, 2017
Figure 12 Plasma Fractionation Market: Company Share Analysis, 2017 (%)
Figure 13 Bio Products Laboratory (BPL): Key Financials
Figure 14 Bio Products Laboratory (BPL): Segmental Revenue
Send an Enquiry@ https://www.marketresearchfuture.com/enquiry/7397
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/plasma-fractionation-market-7397
Source: MarketersMedia
Release ID: 88896809
Copyright © 1999-2013 SproutNews.com
